Filing Details
- Accession Number:
- 0001209191-11-051479
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-11 21:33:29
- Reporting Period:
- 2011-10-07
- Filing Date:
- 2011-10-11
- Accepted Time:
- 2011-10-11 21:33:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1182129 | Auxilium Pharmaceuticals Inc | AUXL | Pharmaceutical Preparations (2834) | 233016883 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219866 | Armando Anido | C/O Auxilium Pharmaceuticals, Inc. 40 Valley Stream Parkway Malvern PA 19355 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-10-07 | 5,275 | $7.81 | 18,928 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-10-07 | 5,275 | $14.23 | 13,653 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nonqualified Stock Option (Right to Buy) | Disposition | 2011-10-07 | 5,275 | $0.00 | 5,275 | $7.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 378,340 | 2016-07-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 21,607 | Indirect | By 2008 GRAT |
| Common Stock | 58,339 | Indirect | By 2009 GRAT |
| Common Stock | 53,537 | Indirect | By 2010 GRAT |
Footnotes
- The option exercise and sale reported on this Form 4 were conducted pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2010.
- This is an average sale price per share and the actual sale prices ranged from $14.15 to $14.33 per share.
- The options fully vested on July 17, 2010.
Billionaire Hedge Funds
